Diagnosis and Management of Bacterial Vaginosis in Pregnant Women

Rizky Aprilia Wikayanti; Bagus Pratama; Rodiani

Authors

Rizky Aprilia Wikayanti Fakultas Kedokteran, Universitas Lampung
Bagus Pratama Fakultas Kedokteran, Universitas Lampung https://orcid.org/0000-0002-1646-0736
Rodiani Fakultas Kedokteran, Universitas Lampung

Keywords:

Diagnosis, Kehamilan, Komplikasi Kehamilan, Tatalaksana, Vaginosis Bakterialis

Abstract

Bacterial vaginosis is a disease that is a public health problem, especially in women, both non-pregnant and pregnant women. Bacterial vaginosis is caused by an excess and overgrowth of anaerobic bacteria such as Gardnerella vaginalis, Ureaplasma urealyticum, Mycoplasma hominis, Mobiluncus sp., Prevotella sp., and other anaerobic bacteria. Bacterial vaginosis is characterized by the presence of an itchy greyish white discharge with a fishy odor, an increase in the pH of the vaginal fluid and is found clue cells on Whiff's test using KOH10%. Management of bacterial vaginosis is in the form of antibiotics with the drug of choice being metronidazole 500 mg orally twice a day for 7 days. In pregnant women, bacterial vaginosis has been reported to increase the incidence of abortion, premature rupture of membranes, preterm labour, low birth weight, and intrauterine infection. Therefore, early diagnosis and appropriate management of bacterial vaginosis can reduce maternal and infant morbidity and mortality.

References

Ranjit, E., Raghubanshi, B. R., Maskey, S., & Parajuli, P. (2018). Prevalence of Bacterial Vaginosis and Its Association with Risk Factors among Nonpregnant Women: A Hospital Based Study. International Journal of Microbiology, 2018, 1–9. doi:10.1155/2018/8349601

Margolis, E., & Fredricks, D. N. (2015). Bacterial Vaginosis-Associated Bacteria. Molecular Medical Microbiology, 1487–1496. doi:10.1016/b978-0-12-397169-2.00083-4

Coudray, M. S., & Madhivanan, P. (2019). Bacterial Vaginosis - A Brief Synopsis of the Literature. European Journal of Obstetrics & Gynecology and Reproductive Biology. doi:10.1016/j.ejogrb.2019.12.035

Bitew, A., Abebaw, Y., Bekele, D., Mihret, A. (2017). Prevalence of Bacterial Vaginosis and Associated Risk Factors Among Women Complaining of Genital Tract Infection. Int. J. Microbiol. 2017, 4919404. doi: 10.1155/2017/4919404

Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D., & Holmes, K. K. (1983). Nonspecific vaginitis. The American Journal of Medicine, 74(1), 14–22. doi:10.1016/0002-9343(83)91112-9

Nugent, R. P., Krohn, M. A., Hillier, S. L. (1991). Reliability of Diagnosing Bacterial Vaginosis Is Improved by a Standardized Method of Gram Stain Interpretation. J. Clin. Microbiol. 29 (2), 297–3015. doi: 10.1128/jcm.29.2.297-301.1991

Sabour, S., Arzanlou, M., Vaez, H., Rahimi, G., Sahebkar, A., & Khademi, F. (2018). Prevalence of bacterial vaginosis in pregnant and non-pregnant Iranian women: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics, 297(5), 1101–1113. doi:10.1007/s00404-018-4722-8

Marrazzo, J. M., Hillier, S. L. (2013). Bacterial Vaginosis. Sex. Transm. Dis., 463–498. doi: 10.1016/B978-0-12-391059-2.00018-8

Shipitsyna, E., Khusnutdinova, T., Budilovskaya, O., Krysanova, A., Shalepo, K., Savicheva, A., et al. (2020). Bacterial Vaginosis-Associated Vaginal Microbiota Is an Age-Independent Risk Factor for Chlamydia Trachomatis, Mycoplasma Genitalium and Trichomonas Vaginalis Infections in Low-Risk Women, St. Petersburg, Russia. Eur. J. Clin. Microbiol. Infect. Dis. 39 (7), 1221–1305. doi: 10.1007/s10096-020-03831-w

Babu, G., Ganvelu Singaravelu, B., Srikumar, R., Reddy, S. V. (2017). Comparative Study on the Vaginal Flora and Incidence of Asymptomatic Vaginosis Among Healthy Women and in Women With Infertility Problems of Reproductive Age. J. Clin. Diagn. Res. 11 (8), DC18. doi: 10.7860/JCDR/2017/28296.10417

Afolabi, B. B., Moses, O. E., & Oduyebo, O. O. (2016). Bacterial Vaginosis and Pregnancy Outcome in Lagos, Nigeria. Open Forum Infectious Diseases, 3(1), ofw030. doi:10.1093/ofid/ofw030

Brown, R. G., Marchesi, J. R., Lee, Y. S., Smith, A., Lehne, B., Kindinger, L. M., et al. (2018). Vaginal Dysbiosis Increases Risk of Preterm Fetal Membrane Rupture, Neonatal Sepsis and Is Exacerbated by Erythromycin. BMC Med. 16 (1), 95. doi: 10.1186/s12916-017-0999-x

Kahwati, L. C., Clark, R., Berkman, N., Urrutia, R., Patel, S. V., Zeng, J., & Viswanathan, M. (2020). Screening for Bacterial Vaginosis in Pregnant Adolescents and Women to Prevent Preterm Delivery. JAMA, 323(13), 1293. doi:10.1001/jama.2020.0233

Workowski, KA., et al., (2021). Sexually transmitted infection treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23. 70(4):1-187.

Anderson MR, Klink K, Cohrssen A. (2004). Evaluation of vaginal complaints. JAMA 2004;291:1368–79. PMID:15026404external icon https://doi.org/10.1001/jama.291.11.1368external icon

Morrill, S., Gilbert, N. M., & Lewis, A. L. (2020). Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the Evidence From in vivo Models. Frontiers in Cellular and Infection Microbiology, 10. doi:10.3389/fcimb.2020.00168

Patterson JL., et al., (2007). Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. AM J Obstet Gynecol. 2007 Aug. 197(2):170.e1-7

Swidsinski A, Mendling W, Loening-Baucke V, et al. (2005). Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005;106:1013–23. PMID:16260520external icon https://doi.org/10.1097/01.AOG.0000183594.45524.d2external icon

Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV., (2019). High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 2019;46:304–11. PMID:30624309external icon https://doi.org/10.1097/OLQ.0000000000000972external icon

Ventolini G.,Hamood A., (2020). Current progresses on vaginal microbiome, bacterial vaginosis and biofilms, GREM Gynecological and Reproductive Endocrinology & Metabolism (2020); 03/2020:136-140 doi: 10.53260/GREM.201031

Tachedjian G, O’Hanion DE, Ravel J. (2018). The implausible “in vivo” role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome. 2018;6(1):29.

Wolrath H, Forsum U, Larsson PG, et al., (2001), Analysis of bacterial vaginosis-related amines in vaginal fluid by gas chromatography and mass spectrometry. J Clin Microbiol. 2001;39(11):4026–4031.

Hodiwala AB, Koli A., (2015). Bacterial vaginosis. Int J Curr Microbiol App Sci. 2015;4(6):530–538.

Cook RL, Reid G, Pond DG, et al., (1989). Clue cells in bacterial vaginosis: immunofluorescent identification of the adherent gram-negative bacteria as Gardnerella vaginalis. J Infect Dis. 1989;160(3):490–496.

Amegashie CP, Gilbert NM, Peipert JF, et al., (2017). Relationship between Nugent score and vaginal epithelial exfoliation. PLoS One. 2017;12(5): e0177797.

Brogden KA, Guthmiller JM, (2002). Polymicrobial Diseases. Washington, DC: ASM Press; 2002.

Kenyon CR, Buyze J, Klebanoff M, Brotman RM., (2018) Association between bacterial vaginosis and partner concurrency: a longitudinal study. Sex Transm Infect 2018;94:75–7. PMID:27645157external icon https://doi.org/10.1136/sextrans-2016-052652external icon

Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK., (2004). Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol 2004;191:1898–906. PMID:15592270external icon https://doi.org/10.1016/j.ajog.2004.06.089external icon

Gondwe T, Ness R, Totten PA, et al., (2020). Novel bacterial vaginosis-associated organisms mediate the relationship between vaginal douching and pelvic inflammatory disease. Sex Transm Infect 2020;96:439–44. PMID:31810995external icon https://doi.org/10.1136/sextrans-2019-054191external icon

Abbai NS, Reddy T, Ramjee G. (2016). Prevalent bacterial vaginosis infection—a risk factor for incident sexually transmitted infections in women in Durban, South Africa. Int J STD AIDS 2016;27:1283–8. PMID:26538552external icon https://doi.org/10.1177/0956462415616038external icon

Morris BJ, Hankins CA, Banerjee J, et al., (2019). Does male circumcision reduce women’s risk of sexually transmitted infections, cervical cancer, and associated conditions? Front Public Health 2019;7:4. PMID:30766863external icon https://doi.org/10.3389/fpubh.2019.00004external icon

Gajer P, Brotman RM, Bai G, et al. (2012). Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012;4:132ra52. PMID:22553250external icon https://doi.org/10.1126/scitranslmed.3003605external icon

Vodstrcil LA, Plummer ME, Fairley CK, et al., (2019). Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial. Sci Rep 2019;9:3555. PMID:30837554external icon https://doi.org/10.1038/s41598-019-39879-8external icon

Brooks JP, Edwards DJ, Blithe DL, et al. (2017). Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception 2017;95:405–13. PMID:27913230external icon https://doi.org/10.1016/j.contraception.2016.11.006external icon

Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. (1996).Validity of the vaginal Gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996;88:573–6. PMID:8841221external icon https://doi.org/10.1016/0029-7844(96)00233-5external icon

Coleman JS, Gaydos CA., (2018). Molecular diagnosis of bacterial vaginosis: an update. J Clin Microbiol 2018;56:e00342-18. PMID:29769280external icon https://doi.org/10.1128/JCM.00342-18external icon

Joesef MR, Hillier SL, Wiknjosastro G, et al., (1995). Intravaginal clindamycin treatment for bacterial vaginosis: Effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527e31.

Brocklehurst P, Gordon A, Heatley E, et al., (2013). Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013 Jan 31;CD000262.

Hauth JC, Goldenberg RL, Andrews WW, et al., (1995). Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732e6.

McDonald HM, O’Loughlin JA, Vigneswaran R, et al., (1994). Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol 1994;84:343e8.

Carey JC, Klebanoff MA, Hauth JC, et al. (2000). Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534e40.

Klebanoff MA, Hauth JC, MacPherson CA, et al. (2004). Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004;190:363e70.

McGregor JA, French JI, Parker R, et al., (1995). Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157e67.

Ugwumadu A, Reid F, Hay P, et al. (2004). Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 2004;104:114e9.

Kekki M, Kurki T, Pelkonen J, et al. (2001). Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97:643e8.

Bhakta, V., Aslam, S., Aljaghwani, A., (2021). Bacterial vaginosis in pregnancy: prevalence and outcomes in a tertiary care hospital. African Journal of Reproductive Health February 2021; 25 (1):49. DOI: 10.29063/ajrh2021/v25i1.6

Aduloju, OP., Akintayo, AA., Aduloju, T., (2019). Prevalence of bacterial vaginosis in pregnancy in a tertiary health institution, south western Nigeria. Pan African Medical Journal. 2019;33:9. doi:10.11604/pamj.2019.33.9.17926

Nigeen W, Bhat AS, Gulzar K, Taing S. (2015). Correlation of bacterial vaginosis with preterm labour: a case control study. Int J Reprod Contracept Obstet Gynecol. 2015; 4: 1868-74.

Das TR, Fatema K, Chowdhury S, Noor F, Ara R, Chakma B, Parveen M, Ali MJB., (2016). Association of bacterial Vaginosis with Preterm Delivery. J Bangladesh Coll Phys Surg. 2016; 34(4): 188-192

Redelinghuys MJ, Ehlers MM, Dreyer AW, Kock MM. (2016). Normal flora and bacterial vaginosis in pregnancy: an overview. Crit Rev Microbiol. 2016; 42(3): 352-363.